News :: Community Pharmacist Aid

FDA issues alert about lack of sterility assurance of drug products from ApotheCure, Inc. and NuVision Pharmacy and of forthcoming recall

15/04/2013 19:31

FDA issues alert about lack of sterility assurance of drug products from ApotheCure, Inc. and NuVision Pharmacy and of forthcoming recall The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that sterile drug...

FDA approves Diclegis for pregnant women experiencing nausea and vomiting

08/04/2013 18:53

FDA approves Diclegis for pregnant women experiencing nausea and vomiting The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting. Diclegis is a...

FDA approves Invokana to treat type 2 diabetes

02/04/2013 20:53

FDA approves Invokana to treat type 2 diabetes The U.S. Food and Drug Administration today approved Invokana (canagliflozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes. Type 2 diabetes is the most common form of the disease,...

FDA approves new multiple sclerosis treatment: Tecfidera

27/03/2013 20:55

FDA approves new multiple sclerosis treatment: Tecfidera The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS). MS is a chronic, inflammatory, autoimmune disease of the...

FDA issues proposal to improve the quality of automated external defibrillators

22/03/2013 09:37

FDA issues proposal to improve the quality of automated external defibrillators The U.S. Food and Drug Administration today issued a proposed order aimed at helping manufacturers improve the quality and reliability of automated external defibrillators (AEDs). The proposed...

FDA approves TOBI Podhaler to treat a type of bacterial lung infection in cystic fibrosis patients

22/03/2013 09:36

FDA approves TOBI Podhaler to treat a type of bacterial lung infection in cystic fibrosis patients The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that...

FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes

22/03/2013 09:35

FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes The U.S. Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs...

FDA approves Dotarem, a new magnetic resonance imaging agent

20/03/2013 07:01

FDA approves Dotarem, a new magnetic resonance imaging agent The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older. Dotarem is...

FDA alerts health care providers of recall of all sterile drug products by Med Prep Consulting in New Jersey

18/03/2013 07:05

FDA alerts health care providers of recall of all sterile drug products by Med Prep Consulting in New Jersey The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of all products produced by Med...

FDA approves Osphena for postmenopausal women experiencing pain during sex

26/02/2013 19:22

FDA approves Osphena for postmenopausal women experiencing pain during sex The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy...

News